Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart rooms watch over cancer patients to prevent falls and confusion

NCT ID NCT07477886

Recruiting now Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study equips hospital rooms with cameras, microphones, and temperature sensors to monitor cancer patients for early signs of delirium, falls, sleep trouble, or mood changes. Researchers hope this technology helps nurses and doctors spot problems sooner and improve patient safety. About 134 hospitalized cancer patients and their clinicians will take part at Mayo Clinic.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help hospitals use smart rooms to catch early warning signs of delirium, falls, or other issues in cancer patients, improving safety and care.
What could go wrong
This is an early observational study, not a treatment trial. The technology may not reliably detect problems or may raise privacy concerns. Results may not apply to other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM MALIGNANT SOLID NEOPLASM

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.